Evidence map›Paper›PMID 25514828›Full record

ArticleVirology journal2014

Kaposi's sarcoma-associated herpesvirus G-protein coupled receptor activates the canonical Wnt/β-catenin signaling pathway.

Magdalena Angelova, MaryBeth Ferris, Kenneth F Swan, Harris E McFerrin, Gabriella Pridjian, Cindy A Morris, Deborah E Sullivan

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Infection of human induced pluripotent stem cells by an oncogenic herpesvirus.Frontiers in cellular and infection microbiology · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Journal of virology · 2019
    Review
  6. Review
  7. Article
  8. Interaction of viral oncogenic proteins with the Wnt signaling pathway.Iranian journal of basic medical sciences · 2018
    Review
  9. Article
  10. Review
  11. Hijacking GPCRs by viral pathogens and tumor.Biochemical pharmacology · 2016
    Review
  12. Article
  13. KSHV Genome Replication and Maintenance.Frontiers in microbiology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Magdalena AngelovaDepartment of Microbiology and Immunology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA, USA. Magdalena_Angelova@hms.harvard.edu.
MaryBeth FerrisDepartment of Microbiology and Immunology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA, USA. mferris@tulane.edu.
Kenneth F SwanDepartment of Obstetrics and Gynecology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA, USA. kswan1@tulane.edu.
Harris E McFerrinBiology Department, Xavier University, 1 Drexel Drive, New Orleans, LA, USA. hmcferri@xula.edu.
Gabriella PridjianDepartment of Obstetrics and Gynecology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA, USA. pridjian@tulane.edu.
Cindy A MorrisDepartment of Microbiology and Immunology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA, USA. Cmorris2@tulane.edu.
Deborah E SullivanDepartment of Microbiology and Immunology, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA, USA. dsulliva@tulane.edu.
Tulane University · USXavier University · US

Funding

STABILITY' (symptomatic review during biologic therapy) Review in Inflammatory Bowel DiseaseP20GM103424 · NIGMS · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI Konstantin G Kousoulas · 2012 to 2026
$57.4M
Human Cytomegalovirus-Induced Inhibition of Cytotrophoblast InvasionR01HD051998 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI MORRIS, CINDY ANNE · 2008 to 2012
$1.5M
HCMV inhibition of cytotrophoblast differentiation through dysregulation of Wnt/?R21HD076283 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI SULLIVAN, DEBORAH E · 2013 to 2014
$409k
NICHD NIH HHS R01 HD051998NICHD NIH HHS R01HD51998NICHD NIH HHS R21 HD076283NICHD NIH HHS R21HD076283NIGMS NIH HHS P20 GM103424NIGMS NIH HHS P20GM103424
6 · The paper itself

Abstract

backgroundKSHV is a tumorigenic γ-herpesvirus that has been identified as the etiologic agent of Kaposi's sarcoma (KS), a multifocal highly vascularized neoplasm that is the most common malignancy associated with acquired immunodeficiency syndrome (AIDS). The virus encodes a constitutively active chemokine receptor homologue, vGPCR that possesses potent angiogenic and tumorigenic properties, and is critical for KSHV pathobiology. To date, a number of signaling pathways have been identified as key in mediating vGPCR oncogenic potential.

findingsIn this study, we identify a novel pathway, the Wnt/β-catenin pathway, which is dysregulated by vGPCR expression in endothelial cells. Expression of vGPCR in endothelial cells enhances the nuclear accumulation of β-catenin, that correlates with an increase in β-catenin transcriptional activity. Activation of β-catenin signaling by vGPCR is dependent on the PI3K/Akt pathway, as treatment of vGPCR-expressing cells with a pharmacological inhibitor of PI3K, leads to a decreased activation of a β-catenin-driven reporter, a significant decrease in expression of β-catenin target genes, and reduced endothelial tube formation.

conclusionsGiven the critical role of Wnt/β-catenin signaling in angiogenesis and tumorigenesis, the findings from this study suggest a novel mechanism in KSHV-induced malignancies.

Indexed as

Host-Pathogen InteractionsWnt Signaling PathwayAnimalsCells, CulturedEndothelial CellsHerpesvirus 8, HumanHumansMice, NudeReceptors, G-Protein-CoupledReceptors, G-Protein-Coupled

Identifiers

PMID25514828
PMCPMC4304609
OpenAlexW2158705724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.